The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- Who Adopts AI First: Endoscopists or Humanoid Robots?
- Quest Diagnostics to offer liver cancer blood test (Becker’s GI & Endoscopy)
- Greater Scope: Doctors Get Inside Look at Gut Health With AI-Powered Endoscopy (NVIDIA)
- State of AI in Medicine (Doximity)
- Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics (Simply Wall Street)
- Will the ‘gestalt’ matter less in GI surgery? (Becker’s GI & Endoscopy)
- Advancing Multidisciplinary Strategies for Obesity Care (AJMC)
- 5 studies scaring gastroenterologists (Becker’s ASC Review)
